INTRODUCTION
H emifacial spasm (HFS) is a hyperactive symptom mainly caused by vessel compression at the root exit zone of facial nerves. The offending vessels are usually arteries; such as anterior (AICA) or posterior (PICA) inferior cerebellar artery, or vertebral artery, but veins are rarely reported, and estimated at fewer than 5%. 1 Microvascular decompression (MVD) is widely accepted as a first choice for HFS, which leads to spasm resolution in over 90% of patients. 2 An abnormal muscle response (AMR) is a typical abnormal muscle reaction in patients with HFS, which is particularly valuable when AMR disappears just after the decompression of facial nerves 3 that is important to help surgeons confirm whether adequate decompression has been achieved. We performed this study applying AMR monitoring during MVD to confirm vein compression in HFS patients.
patients were confirmed to have veins as offending vessels according to intraoperative findings and AMR monitoring. Patients consisted of 4 women and 1 man, whose mean age was 55.6 years old (ranging from 43e72 years old). Three patients had a failed first MVD surgery and received a second surgery: the mean interval between the 2 operations was 16.3 months (4e36 months). The mean follow-up period was 97 months (74e140 months). The patients' clinical characteristics are presented in Table 1 . The study was approved by the institutional review board of Tokyo Women's Medical University (IRB #4879).
Surgical Procedure
One dose of short-acting muscle blockage agent was administered before intubation; total intravenous anesthesia is maintained during the whole operation. The patients were operated on in the lateral decubitus position, using a 3-skullpin head holder to fix the head. Craniotomy was performed using a routine retro-sigmoid approach. 3 After the edge between the transverse and sigmoid sinuses was explored, we opened the dura and arachnoid tissue, gradually exposed the lower cranial nerves, looked upward through the infra-flocculus, and exposed the root exit point (RExP), attached segment (AS), root detachment point (RDP) transition zone, or cisternal portion (CP) 4 of the facial nerve. When the offending vessels were identified, we used a transposition method 5 for decompression for arteries; for veins, we performed dissection and coagulation, or inserted a Teflon prosthesis to achieve decompression.
Intraoperative Monitoring
The auditory brain stem response was monitored in all cases during MVD to preserve hearing. The AMR was used to identify the recognition of offending vessels and to evaluate the effectiveness of decompression. We stimulated the zygomatic branches and recorded the AMR wave from the mentalis muscle. 6 
Follow-Ups
We checked the symptoms on the first postoperative day, at discharge, and in the outpatient clinic later with a face-to-face inquiry.
RESULTS
All 5 patients diagnosed with HFS completed preoperative exams in the outpatient clinic and received scheduled MVD by 1 doctor. None had received Botox treatment previously, and none had been clearly diagnosed with vein compression preoperatively ( Table 1) . Three patients had a failed first MVD and received a second surgery. Among their first procedures, PICA was revealed as the offending vessel in 2 patients, and AICA in 1 patient. AMRs persisted in 2 patients, although they disappeared during the procedure in 1 patient. In their second surgeries, the original decompressed arteries remained transposed from the facial nerve, but veins were found to have adhered or formed girdles around the nerve root. Finally, we coagulated veins or inserted a Teflon prosthesis to complete the decompression. All veins were located at RExP. AMRs disappeared in 2 of the patients, although the peak wave decreased to one third in 1 patient ( Figure 1 ). In the fourth case, PICA was found to compress AS. The AMR did not change when PICA was transposed, which disappeared immediately when the vein under the facial nerve at CP was freed using a Teflon prosthesis ( Figure 2 ). In the fifth case, we first alleviated AICA compression but AMR showed no change. We finally found a small branch of the transverspontine vein crossing at RExP, which was carefully coagulated, and AMR fully resolved.
Outcomes HFS of the 5 patients disappeared within 3 months. Up to the present, HFS has not recurred in these patients. None of the patients experienced any complications, such as hearing loss, facial palsy, or cerebrospinal fluid leakage. The intraoperative findings and outcomes are detailed in Table 1 . Table 1 ). Operative view at the first surgery of a 69-year-old woman (A) shows an anterior inferior cerebellar artery (white arrow) compressing the attached segment of the facial nerve, which was transposed and fixed to the posterior surface of the petrous bone using fibrin glue. In the second surgery (B), the arteries were left transposed and there were no arterial compressions. A small vein (black arrowhead) crossed at the root exit point of the facial nerve (black arrows), which was coagulated. The abnormal muscle response decreased to one third of the initial amplitude (C), serial change from the bottom to second top. therapeutic choice for HFS, with a satisfactory outcome. A variety of methods are employed to improve the effectiveness of procedures, including intraoperative neurophysiological monitoring. An AMR-also called a lateral spread response-is widely used in MVD. Detection of the disappearance of AMR has been reported to be helpful in identifying offending vessels and confirming adequate decompression.
3,6-9 A meta-analysis conducted by Sekula et al. 10 indicated that the chance of cure if AMR was resolved during surgery was 4.2 times greater than if AMR persisted. This suggests the value of confirming AMR. However, there is still some debate on the value of AMR. [11] [12] [13] Some authors suggested that AMR monitoring does not provide significant benefit with respect to the outcome of MVD for HFS. 2 It is true that AMR disappears just after dural incision in some patients, and 1 patient in our series showed disappearance during the first surgery.
Kim et al. 14 studied 299 HFS patients and compared outcomes between groups with the disappearance of AMR before and after MVD, and pointed out that patients with disappearance of AMR after decompression had better outcomes during either short or long-term follow-up. Mooij et al. 15 detailed its role according to diverse categories in guiding or confirming, which resulted in a positive contribution of approximately 87% for intraoperative facial monitoring in MVD for HFS. Wang et al. 16 also reported that intraoperative monitoring with AMR is an effective tool to evaluate adequate decompression involving veins. In patients with AMR persisting at the end of the procedure, facial nerve compression caused by a vein should be examined. We demonstrated that AMR is useful to determine the endpoint in HFS caused by veins.
MVD for HFS leads to satisfactory cure rate, which may reach 90%.
2 Some reasons for failure included misindentification of the actual offending vessels, displacement of an inserted prosthesis, or recompression owing to vessel displacement. 9, 17 Some authors reviewed the second MVD, and offending arteries were found rostral to the VII nerve, between VII and VIII nerves, or in the cisternal segment of the VII root. 9 The inability to identify these arteries or small arterioles led to the inefficiency of MVD, but vein compression was not mentioned as a cause of reoperation. Others found veins as offending vessels in significantly more patients who underwent a second MVD compared to the first MVD. 18 Similar to our study of 3 patients with a second MVD, the arterial vessels were fully decompressed and the main cause of failure was the overlooking of vein compression.
Li et al. 19 reported 13 early repeat MVD (several days after the first surgery) based on the following inclusion criteria: (1) The first MVD failed, the spasm was not resolved at all or became more severe, and (2) AMR persisted during the first MVD or disappeared once but re-emerged after the closure of the dural incision with the same or even at a higher amplitude. All 13 patients had good or excellent spasm resolutions immediately after the reoperation, which involved whole-range exploration and intraoperative AMR monitoring. One patient received a second MVD within a 4-month interval (No. 3 in Table 1 ) who completely failed the first MVD. However, once patients show partial relief, the outcome is different. We question the necessity of early repeat surgeries. According to our experience, many patients show delayed relief-symptoms disappearing after 3 months or longer is quite common. Jo et al. 20 found that among 70 patients with residual or recurrent spasms >1 year after surgery, 11 showed gradual improvement over 3 years, and 1 showed delayed improvement >3 years after surgery. Intraoperative resolution of AMR after decompression and severe indentation were significant predictors of a good long-term outcome after MVD for HFS. Chang et al. 21 reported a probability of delayed ORIGINAL ARTICLE recurrence of 1.0%, 1.7%, and 2.9% at 1 year, 2 years, and 5 years after surgery. Our policy is observation, especially in patients whose symptoms show partial relief. We were concerned about missing responsible vessels, and discussed the possibility of a second MVD. We list 9 reports including our series that focused on veins ( Table 2) . Among them 0%e6.4% of facial spasms were caused by veins. 4, 9, 18, [22] [23] [24] [25] [26] [27] In the second surgery, the number of veins increased. Campos-Benitez and Kaufmann 4 determined the nature of neurovascular compression in 115 consecutive patients undergoing their first MVD for HFS. The primary culprit location was at RExP in 10%, AS in 64%, RDP in 22%, and CP in 3%. They found 3 cases of venous compression in AS, and 1 case in RDP. In our series, 4 cases of venous compression were found in RExP, and 1 in CP, which is not a common location. We would like to stress that we should carefully look for vessels not only in common locations but also at RExP and CP at the second surgery or when AMR persists.
CONCLUSIONS
Veins can be offending vessels in HFS patients, although this is not very common (6.4% in our database). AMR is useful to determine the endpoint in these cases. Once arteries are decompressed thoroughly with residual AMR, surrounding veins at unusual sites, such as RExP or CP, must be checked to prevent persistent HFS. Complete decompression of veins leads to a good clinical outcome.
